Tilray Inc (NASDAQ:TLRY)

79.20
Delayed Data
As of Feb 21
 -1.90 / -2.34%
Today’s Change
20.10
Today|||52-Week Range
300.00
+12.28%
Year-to-Date

Today’s Trading

Previous close81.10
Today’s open81.48
Day’s range78.41 - 83.10
Volume2,177,003
Average volume (3 months)2,958,055
Market cap$7.1B
Data as of 4:00pm ET, 02/21/2019

Growth & Valuation

Earnings growth (last year)-291.93%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+62.43%
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NBIXNeurocrine Bioscienc...-2.05-2.58%
EXASExact Sciences Corp-0.35-0.42%
BLUEbluebird bio Inc-6.20-4.65%
NKTRNektar Therapeutics-2.77-6.44%
Data as of 4:00pm ET, 02/21/2019

Financials

Next reporting dateMarch 19, 2019
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$20.5M
Annual profit (last year)-$7.8M
Net profit margin-38.02%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Brendan Kennedy
Executive Vice President-
Operations
Greg Christopher
Corporate headquarters
Nanaimo, British Columbia

Forecasts